BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21518498)

  • 21. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
    Ringdén O; Schaffer M; Le Blanc K; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):128-34. PubMed ID: 14750078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of graft-versus-host disease on relapse and survival in 100 patients after allogeneic hematopoietic stem cell transplantation].
    Deng XR; Ren HY; Cen XN; Wang LH; Liang ZY; Wang WS; Qiu ZX; Ou JP; Xu WL; Wang MJ; Li Y; Yin Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):994-8. PubMed ID: 19698246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Probability of high resolution full match for human leukocyte antigen loci in unrelated donors and recipients with low resolution match].
    Zhang W; Zhu FM; He YM; Tao SD; Wang W; He JJ; Lü HJ; Yan LX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1617-20. PubMed ID: 21176382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation.
    Spellman S; Klein J; Haagenson M; Askar M; Baxter-Lowe LA; He J; Hsu S; Blasczyk R; Hurley C
    Biol Blood Marrow Transplant; 2012 May; 18(5):739-46. PubMed ID: 21963622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analyses of risk factors for intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Yan FH; Wang M; Huang Y; Jiang EL; Ma QL; Wei JL; Pang AM; Zhang RL; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1020-3. PubMed ID: 24369157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry.
    Crocchiolo R; Ciceri F; Fleischhauer K; Oneto R; Bruno B; Pollichieni S; Sacchi N; Sormani MP; Fanin R; Bandini G; Bonifazi F; Bosi A; Rambaldi A; Alessandrino PE; Falda M; Bacigalupo A
    Bone Marrow Transplant; 2009 Nov; 44(9):571-7. PubMed ID: 19363528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical implications of HLA mismatches in unrelated donor haematopoietic cell transplantation.
    Shaw BE
    Int J Immunogenet; 2008 Aug; 35(4-5):367-74. PubMed ID: 18976440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between HLA tissue type, CMV infection, and acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: single-center experience.
    Kekik C; Besisik SK; Seyhun Y; Oguz FS; Sargin D; Carin MN
    Transplant Proc; 2009 Nov; 41(9):3859-62. PubMed ID: 19917401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch.
    Fuji S; Kanda J; Kato S; Ikegame K; Morishima S; Miyamoto T; Hidaka M; Kubo K; Miyamura K; Tsudo M; Kobayashi H; Maesako Y; Eto T; Adachi S; Ichinohe T; Atsuta Y; Kanda Y;
    Am J Hematol; 2015 Jul; 90(7):618-23. PubMed ID: 25850370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.
    Sasazuki T; Juji T; Morishima Y; Kinukawa N; Kashiwabara H; Inoko H; Yoshida T; Kimura A; Akaza T; Kamikawaji N; Kodera Y; Takaku F
    N Engl J Med; 1998 Oct; 339(17):1177-85. PubMed ID: 9780337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
    Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
    Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of HistoCheck as a Predictor of Clinical Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation.
    Huo MR; Li D; Chang YJ; Xu LP; Zhang XH; Liu KY; Huang XJ
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1866-1872. PubMed ID: 29751115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparison of clinical outcomes between unrelated donor and HLA-haploidentical donor hematopoietic stem cell transplantation].
    Chen F; Wu DP; Sun AN; Ma X; Tang XW; Qiu HY; Miao M; Fu ZZ; Jin ZM; Wang Y; Wu XJ; Chen SN; He GS; Wang XL; Xue SL; Zhao Y; Chang WR
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):83-6. PubMed ID: 18681306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A comparison of clinical characteristics and prognosis of adult acute graft-versus-host disease between human leukocyte antigen- identical and -mismatched allogeneic hematopoietic stem cell transplantation].
    Zhao X; Xu L; Liu D; Han T; Wang Y; Zhang X; Yan C; Chen H; Han W; Wang J; Zhao T; Li Y; Zhang B; Zhao X; Liu K; Huang X
    Zhonghua Nei Ke Za Zhi; 2014 Jan; 53(1):35-9. PubMed ID: 24674726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
    Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients.
    Caocci G; Baccoli R; Vacca A; Mastronuzzi A; Bertaina A; Piras E; Littera R; Locatelli F; Carcassi C; La Nasa G
    Exp Hematol; 2010 May; 38(5):426-33. PubMed ID: 20206661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
    El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
    Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.
    Kurtzberg J; Laughlin M; Graham ML; Smith C; Olson JF; Halperin EC; Ciocci G; Carrier C; Stevens CE; Rubinstein P
    N Engl J Med; 1996 Jul; 335(3):157-66. PubMed ID: 8657213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.